http://www.fpnotebook.com/
Teratogen ExposureAka: Teratogen
- See Also
- General Teratogen Susceptibility
- Week 0-2: Pre-organogenesis
- Not Sensitive to malformation
- Significant exposure is lethal
- Week 3-8: Embryonic Period
- Greatest sensitivity to environmental exposures
- Fetal mass increases 2.5 Million fold first trimester
- Major malformations occur
- Week 9-38: Fetal Period
- Decreasing sensitivity
- Functional defects and minor malformations occur
- Week 0-2: Pre-organogenesis
- Resources
- FDA Hotline regarding teratogen exposure information
- Phone: 1-800-532-3749
- FDA Hotline regarding teratogen exposure information
Teratogens (C0039536) | |
|---|---|
| Definition (MSH) | An agent that causes the production of physical defects in the developing embryo. |
| Definition (CSP) | agent or factor that induces or increases the incidence of a congenital anomaly in the developing embryo. |
| Concepts | Hazardous or Poisonous Substance (T131) |
| MSH | D013723 |
| English | teratogen, Teratogenic substance, Teratogens |
| Spanish | substancia teratogena, sustancia teratogena, teratogeno |
| Parent Concepts | Poisons (C0032346), Pharmaceutical Preparations (C0013227), Noxae (C0028470), Chemical Modifier (C1516451), Duplicate concept (C1274013) |
| Sources | AOD, CSP, MSH, NCI, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
